SMARCD1 and breast carcinoma: BAF60a is directly targeted by members of the tumor-suppressive mi-R99 family in prostate cancer [174], and mi-RNA-mediated post-transcriptional downregulation of BAF60a may play a role in controlling self-renewal in breast cancer-like stem cells [175].